Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Trimarco

Showing results (141-150 of 427) with videos related to

Pageof 43
Sort By:
Clinical Cardiology|November 20, 2010
Prediction of long-term survival in chronic heart failure by multiple biomarker assessment: a 15-year prospective follow-up studyMassimo Volpe, Pietro Francia, Giuliano Tocci, et al.
Journal of Hypertension|October 14, 2004
The Glu27 allele of the beta2 adrenergic receptor increases the risk of cardiac hypertrophy in hypertensionGuido Iaccarino, Francesca Lanni, Ersilia Cipolletta, et al.
Eclinicalmedicine|September 19, 2022
Corrigendum to "Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis."Giuseppe Fiorentino, Antonietta Coppola, Raffaele Izzo, et al.
Cardiovascular Research|March 19, 2024
Persistent increase of cardiovascular and cerebrovascular events in COVID-19 patients: a 3-year population-based analysisAllegra Battistoni, Massimo Volpe, Carmine Morisco, et al.
Giornale Italiano Di Cardiologia (2006)|September 2, 2014
[Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention]Massimo Volpe, Maurizio Giuseppe Abrignani, Claudio Borghi, et al.
Eclinicalmedicine|September 15, 2021
Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysisGiuseppe Fiorentino, Antonietta Coppola, Raffaele Izzo, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|May 20, 2017
2017 Position Paper of the Italian Society for Cardiovascular Prevention (SIPREC) for an Updated Clinical Management of Hypercholesterolemia and Cardiovascular Risk: Executive DocumentMassimo Volpe, Roberto Volpe, Giovanna Gallo, et al.
Journal of Hypertension|May 23, 2002
Increased basal nitric oxide release despite enhanced free radical production in hypertensionAngelo Maffei, Roberta Poulet, Carmine Vecchione, et al.
Cardiovascular Ultrasound|December 5, 2019
Cardiopulmonary exercise testing and echocardiographic exam: an useful interactionCiro Santoro, Regina Sorrentino, Roberta Esposito, et al.
American Journal of Hypertension|June 18, 2014
Prognostic value of combined target-organ damage in patients with essential hypertensionGerardo Carpinella, Gennaro Pagano, Francesco Buono, et al.
Pageof 43

Showing results (141-150 of 427) with videos related to

Sort By:
Pageof 43
Clinical Cardiology|November 20, 2010
Prediction of long-term survival in chronic heart failure by multiple biomarker assessment: a 15-year prospective follow-up studyMassimo Volpe, Pietro Francia, Giuliano Tocci, et al.
Journal of Hypertension|October 14, 2004
The Glu27 allele of the beta2 adrenergic receptor increases the risk of cardiac hypertrophy in hypertensionGuido Iaccarino, Francesca Lanni, Ersilia Cipolletta, et al.
Eclinicalmedicine|September 19, 2022
Corrigendum to "Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis."Giuseppe Fiorentino, Antonietta Coppola, Raffaele Izzo, et al.
Cardiovascular Research|March 19, 2024
Persistent increase of cardiovascular and cerebrovascular events in COVID-19 patients: a 3-year population-based analysisAllegra Battistoni, Massimo Volpe, Carmine Morisco, et al.
Giornale Italiano Di Cardiologia (2006)|September 2, 2014
[Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention]Massimo Volpe, Maurizio Giuseppe Abrignani, Claudio Borghi, et al.
Eclinicalmedicine|September 15, 2021
Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysisGiuseppe Fiorentino, Antonietta Coppola, Raffaele Izzo, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|May 20, 2017
2017 Position Paper of the Italian Society for Cardiovascular Prevention (SIPREC) for an Updated Clinical Management of Hypercholesterolemia and Cardiovascular Risk: Executive DocumentMassimo Volpe, Roberto Volpe, Giovanna Gallo, et al.
Journal of Hypertension|May 23, 2002
Increased basal nitric oxide release despite enhanced free radical production in hypertensionAngelo Maffei, Roberta Poulet, Carmine Vecchione, et al.
Cardiovascular Ultrasound|December 5, 2019
Cardiopulmonary exercise testing and echocardiographic exam: an useful interactionCiro Santoro, Regina Sorrentino, Roberta Esposito, et al.
American Journal of Hypertension|June 18, 2014
Prognostic value of combined target-organ damage in patients with essential hypertensionGerardo Carpinella, Gennaro Pagano, Francesco Buono, et al.
Pageof 43